Evidence map›Paper›PMID 35935364›Full record

ArticleFrontiers in pediatrics2022

Thyroid cancer in children: A multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumors.

Cristina Martucci, Alessandro Crocoli, Maria Debora De Pasquale, Claudio Spinelli, Silvia Strambi, Paolo Brazzarola, Eleonora Morelli, Jessica Cassiani, Juliana Mancera, Juan Pablo Luengas and 15 more

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Cristina MartucciDepartment of Pediatric Surgery, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alessandro CrocoliDepartment of Pediatric Surgery, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Maria Debora De PasqualeDepartment of Pediatric Hematology/Oncology Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Claudio SpinelliDepartment of Pediatric Surgery, University of Pisa, Pisa, Italy.
Silvia StrambiDepartment of Pediatric Surgery, University of Pisa, Pisa, Italy.
Paolo BrazzarolaDepartment of Surgery and Oncology, University and Hospital Trust of Verona, Verona, Italy.
Eleonora MorelliDepartment of Surgery and Oncology, University and Hospital Trust of Verona, Verona, Italy.
Jessica CassianiDepartment of Hepatobiliary Surgery, University of Verona, Verona, Italy.
Juliana ManceraDepartment of Pediatric Surgery, Universidad Militar Nueva Granada, Bogotá, Colombia.
Juan Pablo LuengasDepartment of Pediatric Oncology, National Cancer Institute, Liverpool, Colombia.
Pablo LobosDepartment of Pediatric Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Daniel LibertoDepartment of Pediatric Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Estefanìa AstoriDepartment of Pediatric Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Sabine SarnackiDepartment of Pediatric Surgery, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.
Vincent CouloignerDepartment of Pediatric Otolaryngology, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.
François SimonDepartment of Pediatric Otolaryngology, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.
Cassandre LambertDepartment of Pediatric Otolaryngology, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.
Simone de Campos Vieira AbibDepartment of Pediatric Oncology Surgery and Pediatric Oncology, Pediatric Oncology Institute-GRACC, Federal University of São Paulo, São Paulo, Brazil.
Onivaldo CervantesDepartment of Head and Neck Surgery, Federal University of São Paulo, São Paulo, Brazil.
Eliana CaranDepartment of Pediatric Oncology Surgery and Pediatric Oncology, Pediatric Oncology Institute-GRACC, Federal University of São Paulo, São Paulo, Brazil.
Diana Delgado LindmanDepartment of Pediatric Oncology Surgery and Pediatric Oncology, Pediatric Oncology Institute-GRACC, Federal University of São Paulo, São Paulo, Brazil.
Matthew O JonesDepartment of Pediatric Surgery, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Rajeev ShuklaDepartment of Pathology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Paul D LostyDepartment of Pediatric Surgery, Faculty of Health and Life Sciences, Alder Hey Children's Hospital NHS Foundation Trust, University of Liverpool, Liverpool, United Kingdom.
Alessandro InserraDepartment of Pediatric Surgery, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thyroid gland malignancies are rare in pediatric patients (0.7% of tumors); only 1.8% are observed in patients aged <20 years, with a higher prevalence recorded in women and adolescents. Risk factors include genetic syndromes, MEN disorders, autoimmune diseases, and exposure to ionizing radiation. Radiotherapy is also associated with an increased risk of secondary thyroid cancer. This study describes the clinical features and surgical outcomes of primary and secondary thyroid tumors in pediatric patients. Methods: Institutional data were collected from eight international surgical oncology centers for pediatric patients with thyroid cancer between 2000 and 2020. Statistical analyses were performed using the GraphPad Prism software. Results: Among 255 total cases of thyroid cancer, only 13 (5.1%) were secondary tumors. Primary thyroid malignancies were more likely to be multifocal in origin (odds ratio [OR] 1.993, 95% confidence interval [CI].7466-5.132, Conclusions: This multicenter study demonstrated excellent survival in pediatric thyroid malignancies. Secondary tumors exhibited greater disease relapse (15.8 vs. 10.5%) and a higher incidence of surgical complications (36.8 vs. 22.2%).

Indexed as

cancercarcinomachildrensurgerythyroid

Identifiers

PMID35935364
PMCPMC9354958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.